Bill Martin, MBA
Chief Operating Officer
As Chief Operating Officer of Core Bio, Bill brings more than 20 years of experience in biotechnology business development, corporate strategy, financing, transactions and operations. Most recently, he served as an advisor on the $1 billion acquisition of SiteOne Therapeutics by Lilly. Before co-founding Core Biotherapeutics, he served as Executive Vice President of Corporate Development and Operations at Exalys Therapeutics and led business development and commercial strategy at Adynxx. Previously, he held an operational leadership role at Corthera, supporting activities that culminated in its $620 million acquisition by Novartis. Bill has supported public and venture-backed companies on pipeline strategy, corporate development, business operations and transaction execution, with additional experience at BCG. Bill holds a bachelor’s degree in engineering sciences and economics from Dartmouth College and an MBA from MIT Sloan.